FSA Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.21K Hold
18
﹤0.01% 522
2025
Q2
$1.57K Hold
18
﹤0.01% 486
2025
Q1
$1.23K Hold
18
﹤0.01% 466
2024
Q4
$1.4K Hold
18
﹤0.01% 506
2024
Q3
$1.21K Buy
+18
New +$1.48K ﹤0.01% 518
2024
Q1
$2.5K Hold
18
﹤0.01% 526
2023
Q4
$2K Buy
+18
New +$1.84K ﹤0.01% 525
2020
Q2
Sell
-100
Closed -$7K 393
2020
Q1
$7K Sell
100
-100
-50% -$6.22K 0.01% 278
2019
Q4
$11K Buy
+200
New +$9.49K 0.01% 291

Other funds holding DXCM

FSA Wealth Management's DXCM Position: Q3 2025 in Review

FSA Wealth Management held its DexCom (DXCM) position steady in Q3 2025 at 18 shares worth $1.21K. The position accounts for ﹤0.01% of the portfolio, ranked #522.

FSA Wealth Management first reported a position in DXCM in Q4 2019 and has held it in 9 quarters since. The position peaked at $11K in Q4 2019. 910 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • FSA Wealth Management held 18 shares of DexCom worth $1.21K as of Q3 2025.
  • FSA Wealth Management left its DexCom share count unchanged in Q3 2025.
  • DexCom made up ﹤0.01% of FSA Wealth Management's portfolio in Q3 2025, its #522 holding.
  • FSA Wealth Management first reported a position in DexCom in Q4 2019 and has held it in 9 quarters since.
  • FSA Wealth Management's DexCom position peaked at $11K in Q4 2019.
  • 910 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on FSA Wealth Management's 13F filing for Q3 2025, filed 17 Nov 2025.